24RS HB 229

Actions

Last Action	01/10/24: to Committee on Committees (H)
Title	AN ACT relating to gene therapy.
Bill Documents	Introduced
Bill Request Number	21
Sponsors	E. Callaway, J. Decker, D. Bentley, J. Hodgson, M. Proctor, S. Rawlings
Summary of Original Version	Create a new section of KRS 217.005 to 217.215, the Kentucky Food, Drug, and Cosmetic Act, to define terms; require products that are known to be or could act as gene therapy to be labeled with the words "Potential Gene Therapy Product" or "Gene Therapy Product"; require any entity in the state that produces, sells, or distributes a product in this state with the capacity to infect an individual with a disease or to expose an individual with genetically modified material to provide information upon request on how individuals may be exposed; require informed consent before any entity makes available a product in this state that would act as a medical intervention, vaccine, drug, or genetic modification.
Index Headings of Original Version	Diseases - Gene therapy or genetic change, label and informed consent, requirements Drugs and Medicines - Gene therapy or genetic change, label and informed consent, requirements Foods - Gene therapy or genetic change, label and informed consent, requirements Hazardous Materials - Gene therapy or genetic change, label and informed consent, requirements Public Health - Gene therapy or genetic change, label and informed consent, requirements